TECH earnings: real EPS beat/miss history, analyst consensus Buy, P/E 101.10. Updated 2026-07-23.
Bio-Techne (TECH) Research Hub
Bio-Techne (TECH) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 72.12 USD (-0.18%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 101.10, market cap 11.22B. This hub links to the full technical, earnings and options research available for TECH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 72.12 USD (-0.18%) |
| 52-week range | 54.32 USD – 72.62 USD |
| Trend regime | Range |
| 14-day RSI | 44.3 (Bearish) |
| Trailing P/E | 101.10 |
| Market cap | 11.22B |
| Dividend yield | 0.45% |
Available research for TECH
Covered Call on TECH: how it works, illustrative setup around the real 72.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TECH: how it works, illustrative setup around the real 72.12 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TECH: how it works, illustrative setup around the real 72.12 USD price, max profit/loss, breakeven and when to use it. Educational.
TECH technical analysis: range, last 72.12 USD, RSI 44.3, 52w range 54.32 USD–72.62 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TECH in?
Bio-Techne (TECH) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is TECH in an uptrend or downtrend?
As of 2026-09-11, TECH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TECH's trailing P/E ratio?
TECH's trailing P/E is 101.10, with a market cap of 11.22B. See the earnings research page for full valuation detail.